血清素与人类血清素载体的结合. 分子建模和实验验证
Leyla Celik1, Steffen Sinning, Kasper Severinsen
1The iNANO and inSPIN Centers, the Department of Chemistry, University of Aarhus, Aarhus, Denmark.
Journal of the American Chemical Society
|March 5, 2008
概括
分子建模和结构-活性关系研究阐明了血清素 (5-HT) 与人类血清素载体 (hSERT) 的结合. 实验证实了关键的相互作用,支持一个模型,其中5-HT.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 计算化学的计算化学
背景情况:
- 人类类胺转运体 (hSERT) 是治疗神经和精神疾病的关键点.
- 了解血清素 (5-HT) 与hSERT的精确结合机制对于合理的药物设计至关重要.
- 之前的模型缺乏对5-HT/hSERT相互作用的详细结构洞察力.
研究的目的:
- 提出一种用于将血清素 (5-HT) 与人类血清素转运体 (hSERT) 结合的分子模型.
- 通过实验验证拟议的结合相互作用,使用局部导向的突变发生和配体类比研究.
- 阐明涉及5HT与hSERT结合的特定方向和关键残留物.
主要方法:
- 基于细菌氨酸载体晶体结构的hSERT同质模型的构建.
- 诱导5-HT的合适对接到同质模型中,以预测结合模式.
- 实验验证使用配对突变链体模拟补充 (PaMLAC) 来测量5-HT模拟物与野生类型和突变hSERT的结合亲缘关系.
主要成果:
- 确定了5-HT的两种潜在结合模式,两种都涉及Asp98和5-HT氨基之间的盐桥.
- 在两个预测模式中,内环的C6位置始终指向Ala173.
- PaMLAC实验证实了Asp98-胺和C6-Ala173的相互作用,并支持一个结合模式,其中5基离子组接近Thr439.
结论:
- 建立了对5-HT与hSERT结合的验证模型,详细介绍了关键的配体-蛋白相互作用.
- 这项研究证实了Asp98和Ala173在固5-HT.中的作用.
- 这些发现为理解hSERT功能和开发向治疗提供了精细的结构基础.
相关概念视频
The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
The Significance of Membrane Transport
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...


